Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
A Randomized Phase III Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD After Unrelated Donor Hematopoietic Cell Transplantation Using Nonmyeloablative Conditioning for Patients With Hematologic Malignancies: A Multi-center Trial
Status: Enrolling
Updated:  2/13/2018
University of Colorado
mi
from
Denver, CO
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
A Randomized Phase III Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD After Unrelated Donor Hematopoietic Cell Transplantation Using Nonmyeloablative Conditioning for Patients With Hematologic Malignancies: A Multi-center Trial
Status: Enrolling
Updated: 2/13/2018
University of Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
A Randomized Phase III Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD After Unrelated Donor Hematopoietic Cell Transplantation Using Nonmyeloablative Conditioning for Patients With Hematologic Malignancies: A Multi-center Trial
Status: Enrolling
Updated:  2/13/2018
Presbyterian - Saint Lukes Medical Center - Health One
mi
from
Denver, CO
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
A Randomized Phase III Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD After Unrelated Donor Hematopoietic Cell Transplantation Using Nonmyeloablative Conditioning for Patients With Hematologic Malignancies: A Multi-center Trial
Status: Enrolling
Updated: 2/13/2018
Presbyterian - Saint Lukes Medical Center - Health One
mi
from
Denver, CO
Click here to add this to my saved trials
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
A Randomized Phase III Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD After Unrelated Donor Hematopoietic Cell Transplantation Using Nonmyeloablative Conditioning for Patients With Hematologic Malignancies: A Multi-center Trial
Status: Enrolling
Updated:  2/13/2018
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
A Randomized Phase III Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD After Unrelated Donor Hematopoietic Cell Transplantation Using Nonmyeloablative Conditioning for Patients With Hematologic Malignancies: A Multi-center Trial
Status: Enrolling
Updated: 2/13/2018
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
A Randomized Phase III Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD After Unrelated Donor Hematopoietic Cell Transplantation Using Nonmyeloablative Conditioning for Patients With Hematologic Malignancies: A Multi-center Trial
Status: Enrolling
Updated:  2/13/2018
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
A Randomized Phase III Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD After Unrelated Donor Hematopoietic Cell Transplantation Using Nonmyeloablative Conditioning for Patients With Hematologic Malignancies: A Multi-center Trial
Status: Enrolling
Updated: 2/13/2018
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
A Randomized Phase III Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD After Unrelated Donor Hematopoietic Cell Transplantation Using Nonmyeloablative Conditioning for Patients With Hematologic Malignancies: A Multi-center Trial
Status: Enrolling
Updated:  2/13/2018
VA Puget Sound Health Care System
mi
from
Seattle, WA
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
A Randomized Phase III Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD After Unrelated Donor Hematopoietic Cell Transplantation Using Nonmyeloablative Conditioning for Patients With Hematologic Malignancies: A Multi-center Trial
Status: Enrolling
Updated: 2/13/2018
VA Puget Sound Health Care System
mi
from
Seattle, WA
Click here to add this to my saved trials
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
A Randomized Phase III Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD After Unrelated Donor Hematopoietic Cell Transplantation Using Nonmyeloablative Conditioning for Patients With Hematologic Malignancies: A Multi-center Trial
Status: Enrolling
Updated:  2/13/2018
Fred Hutch/University of Washington Cancer Consortium
mi
from
Seattle, WA
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
A Randomized Phase III Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD After Unrelated Donor Hematopoietic Cell Transplantation Using Nonmyeloablative Conditioning for Patients With Hematologic Malignancies: A Multi-center Trial
Status: Enrolling
Updated: 2/13/2018
Fred Hutch/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
A Randomized Phase III Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD After Unrelated Donor Hematopoietic Cell Transplantation Using Nonmyeloablative Conditioning for Patients With Hematologic Malignancies: A Multi-center Trial
Status: Enrolling
Updated:  2/13/2018
Aarhus University Hospital
mi
from
Arhus,
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
A Randomized Phase III Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD After Unrelated Donor Hematopoietic Cell Transplantation Using Nonmyeloablative Conditioning for Patients With Hematologic Malignancies: A Multi-center Trial
Status: Enrolling
Updated: 2/13/2018
Aarhus University Hospital
mi
from
Arhus,
Click here to add this to my saved trials
Acupuncture in Treating Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer
A Phase III Prospective Randomized Trial of Acupuncture for Treatment of Radiation-Induced Xerostomia in Patients With Head and Neck Cancer
Status: Enrolling
Updated:  2/13/2018
CCOP Research Base Sites
mi
from
Houston, TX
Acupuncture in Treating Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer
A Phase III Prospective Randomized Trial of Acupuncture for Treatment of Radiation-Induced Xerostomia in Patients With Head and Neck Cancer
Status: Enrolling
Updated: 2/13/2018
CCOP Research Base Sites
mi
from
Houston, TX
Click here to add this to my saved trials
Standard Maintenance POMP/D Plus Ixazomib Maintenance Therapy in Adult Patients With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed Phenotype Acute Leukemia in Complete Remission (CR)
Standard Maintenance [POMP/D (Methotrexate, 6 - Mercaptopurine, Vincristine, Prednisone/Dexamethasone)] Plus Ixazomib Maintenance Therapy in Adults With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed Phenotype Acute Leukemia in Complete Remission (CR)
Status: Enrolling
Updated:  2/13/2018
Froedtert and the Medical College of Wisconsin
mi
from
Milwaukee, WI
Standard Maintenance POMP/D Plus Ixazomib Maintenance Therapy in Adult Patients With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed Phenotype Acute Leukemia in Complete Remission (CR)
Standard Maintenance [POMP/D (Methotrexate, 6 - Mercaptopurine, Vincristine, Prednisone/Dexamethasone)] Plus Ixazomib Maintenance Therapy in Adults With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed Phenotype Acute Leukemia in Complete Remission (CR)
Status: Enrolling
Updated: 2/13/2018
Froedtert and the Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Status: Enrolling
Updated:  2/13/2018
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Status: Enrolling
Updated: 2/13/2018
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Status: Enrolling
Updated:  2/13/2018
University of Colorado Health Sciences Center and The Children's Hospital
mi
from
Aurora, CO
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Status: Enrolling
Updated: 2/13/2018
University of Colorado Health Sciences Center and The Children's Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Status: Enrolling
Updated:  2/13/2018
Pediatrix Hematology/Oncology University of Florida College of Medicine
mi
from
Gainesville, FL
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Status: Enrolling
Updated: 2/13/2018
Pediatrix Hematology/Oncology University of Florida College of Medicine
mi
from
Gainesville, FL
Click here to add this to my saved trials
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Status: Enrolling
Updated:  2/13/2018
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Status: Enrolling
Updated: 2/13/2018
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Status: Enrolling
Updated:  2/13/2018
Vanderbilt Children's Hospital
mi
from
Nashville, TN
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Status: Enrolling
Updated: 2/13/2018
Vanderbilt Children's Hospital
mi
from
Nashville, TN
Click here to add this to my saved trials
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Status: Enrolling
Updated:  2/13/2018
M.D. Anderson Comprehensive Cancer Center
mi
from
Houston, TX
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Status: Enrolling
Updated: 2/13/2018
M.D. Anderson Comprehensive Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Status: Enrolling
Updated:  2/13/2018
Southern Alberta Children's Cancer Program
mi
from
Calgary,
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Status: Enrolling
Updated: 2/13/2018
Southern Alberta Children's Cancer Program
mi
from
Calgary,
Click here to add this to my saved trials
Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas
A Pilot Study of Sutent®/Sunitinib (SU11248), an Oral Multi-Targeted Tyrosine Kinase Inhibitor in Subjects With NF-1 Plexiform Neurofibromas
Status: Enrolling
Updated:  2/14/2018
Riley Hospital for Children at IU Health
mi
from
Indianapolis, IN
Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas
A Pilot Study of Sutent®/Sunitinib (SU11248), an Oral Multi-Targeted Tyrosine Kinase Inhibitor in Subjects With NF-1 Plexiform Neurofibromas
Status: Enrolling
Updated: 2/14/2018
Riley Hospital for Children at IU Health
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Prenatal Screening for Down Syndrome With DNAFirst
DNAFirst: Primary Screening for Down Syndrome by Maternal Plasma DNA
Status: Enrolling
Updated:  2/19/2018
Women and Infants Hospital of Rhode Island
mi
from
Providence, RI
Prenatal Screening for Down Syndrome With DNAFirst
DNAFirst: Primary Screening for Down Syndrome by Maternal Plasma DNA
Status: Enrolling
Updated: 2/19/2018
Women and Infants Hospital of Rhode Island
mi
from
Providence, RI
Click here to add this to my saved trials
Autologous Bone Marrow Harvest and Transplant for Sensorineural Hearing Loss
Safety of Infusion of Autologous Human Bone Marrow Mononuclear Fraction in Children With Sensorineural Hearing Loss
Status: Enrolling
Updated:  2/20/2018
Florida Hospital for Children
mi
from
Orlando, FL
Autologous Bone Marrow Harvest and Transplant for Sensorineural Hearing Loss
Safety of Infusion of Autologous Human Bone Marrow Mononuclear Fraction in Children With Sensorineural Hearing Loss
Status: Enrolling
Updated: 2/20/2018
Florida Hospital for Children
mi
from
Orlando, FL
Click here to add this to my saved trials
Super Power in BAI
Hearing Outcomes Using Super-power Processors in Bone Anchored Implant Recipients
Status: Enrolling
Updated:  2/20/2018
University of Miami Department of Otolaryngology
mi
from
Miami, FL
Super Power in BAI
Hearing Outcomes Using Super-power Processors in Bone Anchored Implant Recipients
Status: Enrolling
Updated: 2/20/2018
University of Miami Department of Otolaryngology
mi
from
Miami, FL
Click here to add this to my saved trials
CI532 - Early Experience Study
Implantation With the Cochlear Nucleus® CI532 Implant - Early Experience Study
Status: Enrolling
Updated:  2/20/2018
NorthShore University
mi
from
Skokie, IL
CI532 - Early Experience Study
Implantation With the Cochlear Nucleus® CI532 Implant - Early Experience Study
Status: Enrolling
Updated: 2/20/2018
NorthShore University
mi
from
Skokie, IL
Click here to add this to my saved trials
CI532 - Early Experience Study
Implantation With the Cochlear Nucleus® CI532 Implant - Early Experience Study
Status: Enrolling
Updated:  2/20/2018
University of Iowa
mi
from
Iowa City, IA
CI532 - Early Experience Study
Implantation With the Cochlear Nucleus® CI532 Implant - Early Experience Study
Status: Enrolling
Updated: 2/20/2018
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
CI532 - Early Experience Study
Implantation With the Cochlear Nucleus® CI532 Implant - Early Experience Study
Status: Enrolling
Updated:  2/20/2018
University of Michigan
mi
from
Ann Arbor, MI
CI532 - Early Experience Study
Implantation With the Cochlear Nucleus® CI532 Implant - Early Experience Study
Status: Enrolling
Updated: 2/20/2018
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
CI532 - Early Experience Study
Implantation With the Cochlear Nucleus® CI532 Implant - Early Experience Study
Status: Enrolling
Updated:  2/20/2018
Center for Hearing and Balance
mi
from
Chesterfield, MO
CI532 - Early Experience Study
Implantation With the Cochlear Nucleus® CI532 Implant - Early Experience Study
Status: Enrolling
Updated: 2/20/2018
Center for Hearing and Balance
mi
from
Chesterfield, MO
Click here to add this to my saved trials
CI532 - Early Experience Study
Implantation With the Cochlear Nucleus® CI532 Implant - Early Experience Study
Status: Enrolling
Updated:  2/20/2018
Vanderbilt University Medical Center
mi
from
Nashville, TN
CI532 - Early Experience Study
Implantation With the Cochlear Nucleus® CI532 Implant - Early Experience Study
Status: Enrolling
Updated: 2/20/2018
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
CI532 - Early Experience Study
Implantation With the Cochlear Nucleus® CI532 Implant - Early Experience Study
Status: Enrolling
Updated:  2/20/2018
Dallas Ear Institute
mi
from
Dallas, TX
CI532 - Early Experience Study
Implantation With the Cochlear Nucleus® CI532 Implant - Early Experience Study
Status: Enrolling
Updated: 2/20/2018
Dallas Ear Institute
mi
from
Dallas, TX
Click here to add this to my saved trials
Optimizing Sleep/Wake Related Cognitive Efficacy
Optimizing Sleep/Wake Related Cognitive Efficacy in Laborist Shifts: Toward Establishing Models of Safer Obstetrical Care
Status: Enrolling
Updated:  2/21/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Optimizing Sleep/Wake Related Cognitive Efficacy
Optimizing Sleep/Wake Related Cognitive Efficacy in Laborist Shifts: Toward Establishing Models of Safer Obstetrical Care
Status: Enrolling
Updated: 2/21/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Status: Enrolling
Updated:  2/21/2018
Indiana University Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Status: Enrolling
Updated: 2/21/2018
Indiana University Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Status: Enrolling
Updated:  2/21/2018
Sidney and Lois Eskenazi Hospital
mi
from
Indianapolis, IN
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Status: Enrolling
Updated: 2/21/2018
Sidney and Lois Eskenazi Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease
Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease
Status: Enrolling
Updated:  2/23/2018
University of Rochester
mi
from
Rochester, NY
Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease
Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease
Status: Enrolling
Updated: 2/23/2018
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
The Autonomic Nervous System and Obesity
The Autonomic Nervous System and Obesity
Status: Enrolling
Updated:  2/27/2018
Vanderbilt University
mi
from
Nashville, TN
The Autonomic Nervous System and Obesity
The Autonomic Nervous System and Obesity
Status: Enrolling
Updated: 2/27/2018
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated:  2/27/2018
Study Site 404
mi
from
Phoenix, AZ
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated: 2/27/2018
Study Site 404
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated:  2/27/2018
Study Site 412
mi
from
Gainesville, FL
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated: 2/27/2018
Study Site 412
mi
from
Gainesville, FL
Click here to add this to my saved trials
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated:  2/27/2018
Study Site 368
mi
from
Tampa, FL
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated: 2/27/2018
Study Site 368
mi
from
Tampa, FL
Click here to add this to my saved trials
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated:  2/27/2018
Study Site 03
mi
from
Lincoln, NE
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated: 2/27/2018
Study Site 03
mi
from
Lincoln, NE
Click here to add this to my saved trials
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated:  2/27/2018
Study Site 16024
mi
from
Winston-Salem, NC
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated: 2/27/2018
Study Site 16024
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated:  2/27/2018
Study Site 413
mi
from
Seattle, WA
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated: 2/27/2018
Study Site 413
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated:  2/27/2018
Study Site 402
mi
from
Washington,
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated: 2/27/2018
Study Site 402
mi
from
Washington,
Click here to add this to my saved trials
Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss
Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss
Status: Enrolling
Updated:  3/1/2018
Florida Hospital
mi
from
Orlando, FL
Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss
Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss
Status: Enrolling
Updated: 3/1/2018
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
Vitamin D Supplementation in Older Adults With Urinary Incontinence
Vitamin D Supplementation in Older Adults With Urinary Incontinence
Status: Enrolling
Updated:  3/7/2018
UAB Continence Clinic at The Kirklin Clinic
mi
from
Birmingham, AL
Vitamin D Supplementation in Older Adults With Urinary Incontinence
Vitamin D Supplementation in Older Adults With Urinary Incontinence
Status: Enrolling
Updated: 3/7/2018
UAB Continence Clinic at The Kirklin Clinic
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Status: Enrolling
Updated:  3/8/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Status: Enrolling
Updated: 3/8/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Status: Enrolling
Updated:  3/8/2018
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Status: Enrolling
Updated: 3/8/2018
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Status: Enrolling
Updated:  3/8/2018
University of Chicago
mi
from
Chicago, IL
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Status: Enrolling
Updated: 3/8/2018
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Status: Enrolling
Updated:  3/8/2018
Children' Hospital Boston
mi
from
Boston, MA
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Status: Enrolling
Updated: 3/8/2018
Children' Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Status: Enrolling
Updated:  3/8/2018
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Status: Enrolling
Updated: 3/8/2018
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Status: Enrolling
Updated:  3/8/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Status: Enrolling
Updated: 3/8/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Status: Enrolling
Updated:  3/8/2018
Childrens Medical Center - Univ. of Texas SW Medical Center
mi
from
Dallas, TX
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Status: Enrolling
Updated: 3/8/2018
Childrens Medical Center - Univ. of Texas SW Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Status: Enrolling
Updated:  3/8/2018
University of Utah
mi
from
Salt Lake City, UT
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Status: Enrolling
Updated: 3/8/2018
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Status: Enrolling
Updated:  3/8/2018
Children's Hospital at Westmead
mi
from
Westmead,
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Status: Enrolling
Updated: 3/8/2018
Children's Hospital at Westmead
mi
from
Westmead,
Click here to add this to my saved trials
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Status: Enrolling
Updated:  3/8/2018
NIH
mi
from
Bethesda, MD
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Status: Enrolling
Updated: 3/8/2018
NIH
mi
from
Bethesda, MD
Click here to add this to my saved trials